Alan Cass

27.9k total citations · 5 hit papers
352 papers, 15.4k citations indexed

About

Alan Cass is a scholar working on Nephrology, General Health Professions and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Alan Cass has authored 352 papers receiving a total of 15.4k indexed citations (citations by other indexed papers that have themselves been cited), including 142 papers in Nephrology, 61 papers in General Health Professions and 59 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Alan Cass's work include Dialysis and Renal Disease Management (99 papers), Chronic Kidney Disease and Diabetes (73 papers) and Organ Donation and Transplantation (41 papers). Alan Cass is often cited by papers focused on Dialysis and Renal Disease Management (99 papers), Chronic Kidney Disease and Diabetes (73 papers) and Organ Donation and Transplantation (41 papers). Alan Cass collaborates with scholars based in Australia, United Kingdom and New Zealand. Alan Cass's co-authors include Vlado Perkovic, Martin Gallagher, Bruce Neal, Meg Jardine, Toshiharu Ninomiya, Anushka Patel, Joan Cunningham, John Chalmers, Steven J. Chadban and Kirsten Howard and has published in prestigious journals such as New England Journal of Medicine, The Lancet and SHILAP Revista de lepidopterología.

In The Last Decade

Alan Cass

345 papers receiving 14.9k citations

Hit Papers

Worldwide access to treatment for end-stage kidney disea... 2009 2026 2014 2020 2015 2012 2009 2010 2017 400 800 1.2k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alan Cass Australia 61 6.4k 2.8k 2.7k 2.1k 2.1k 352 15.4k
Keith C. Norris United States 69 5.5k 0.9× 1.4k 0.5× 2.0k 0.7× 2.4k 1.1× 1.6k 0.8× 464 16.5k
Scott Klarenbach Canada 60 5.9k 0.9× 2.8k 1.0× 1.8k 0.7× 2.6k 1.2× 1.0k 0.5× 309 13.9k
Vivekanand Jha India 58 7.8k 1.2× 2.2k 0.8× 1.4k 0.5× 2.0k 1.0× 959 0.5× 584 17.5k
Braden Manns Canada 80 9.8k 1.5× 3.1k 1.1× 2.9k 1.1× 2.4k 1.1× 2.0k 1.0× 478 22.3k
Natasha Wiebe Canada 53 3.8k 0.6× 2.1k 0.8× 1.9k 0.7× 1.3k 0.6× 1.1k 0.5× 146 11.5k
Ethan M. Balk United States 62 2.9k 0.5× 4.8k 1.7× 2.8k 1.0× 1.9k 0.9× 2.1k 1.0× 265 17.7k
Angela C Webster Australia 63 3.7k 0.6× 3.0k 1.1× 1.1k 0.4× 1.9k 0.9× 1.0k 0.5× 298 15.6k
Shunichi Fukuhara Japan 53 3.5k 0.5× 2.1k 0.8× 1.4k 0.5× 1.8k 0.8× 645 0.3× 372 13.4k
Suetonia C. Palmer New Zealand 58 5.4k 0.8× 1.7k 0.6× 1.6k 0.6× 1.1k 0.5× 1.0k 0.5× 215 10.7k
Brenda R. Hemmelgarn Canada 85 11.3k 1.8× 3.6k 1.3× 5.5k 2.0× 3.2k 1.5× 2.8k 1.3× 569 29.5k

Countries citing papers authored by Alan Cass

Since Specialization
Citations

This map shows the geographic impact of Alan Cass's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan Cass with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan Cass more than expected).

Fields of papers citing papers by Alan Cass

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan Cass. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan Cass. The network helps show where Alan Cass may publish in the future.

Co-authorship network of co-authors of Alan Cass

This figure shows the co-authorship network connecting the top 25 collaborators of Alan Cass. A scholar is included among the top collaborators of Alan Cass based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan Cass. Alan Cass is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Howard, Kirsten, Gail Garvey, Kate Anderson, et al.. (2024). Development of the What Matters 2 Adults (WM2A) wellbeing measure for Aboriginal and Torres Strait Islander adults. Social Science & Medicine. 347. 116694–116694. 5 indexed citations
2.
Majoni, Sandawana William, Jane Nelson, Jessica Graham, et al.. (2023). Comparison of two ferritin assay platforms to assess their level of agreement in measuring serum and plasma ferritin levels in patients with chronic kidney disease. BMC Nephrology. 24(1). 198–198. 3 indexed citations
3.
Barden, Anne, Andrea K. Viecelli, Ashley Irish, et al.. (2021). Dietary habits in Australian, New Zealand and Malaysian patients with end stage kidney failure: A pre‐specified cross‐sectional study of the FAVOURED trial participants. Journal of Human Nutrition and Dietetics. 35(6). 1178–1191. 1 indexed citations
4.
Viecelli, Andrea K., Kevan R. Polkinghorne, Elaine M. Pascoe, et al.. (2019). Fish oil and aspirin effects on arteriovenous fistula function: Secondary outcomes of the randomised omega-3 fatty acids (Fish oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) trial. PLoS ONE. 14(3). e0213274–e0213274. 28 indexed citations
5.
Barr, Elizabeth, Federica Barzi, Jaquelyne T. Hughes, et al.. (2018). High Baseline Levels of Tumor Necrosis Factor Receptor 1 Are Associated With Progression of Kidney Disease in Indigenous Australians With Diabetes: The eGFR Follow-up Study. Diabetes Care. 41(4). 739–747. 30 indexed citations
6.
Weisbord, Steven D., Martin Gallagher, Hani Jneid, et al.. (2017). Outcomes after Angiography with Sodium Bicarbonate and Acetylcysteine. New England Journal of Medicine. 378(7). 603–614. 292 indexed citations breakdown →
7.
Barr, Elizabeth, Federica Barzi, Jaquelyne T. Hughes, et al.. (2017). THE ROLE OF TUMOUR NECROSIS FACTOR RECEPTOR 1 (TNFR1) IN THE PROGRESSION OF KIDNEY DISEASE IN INDIGENOUS AUSTRALIANS: THE EGFR FOLLOW-UP STUDY. Nephrology. 22. 18–18. 2 indexed citations
8.
Gummer, Joel P. A., Robert D. Trengove, Elaine M. Pascoe, et al.. (2016). Association between serum hepcidin‐25 and primary resistance to erythropoiesis‐stimulating agents in chronic kidney disease: a secondary analysis of the HERO trial. Nephrology. 22(7). 548–554. 14 indexed citations
9.
Mooney, John, Isuru Ranasinghe, Clara K Chow, et al.. (2013). Preoperative Estimates of Glomerular Filtration Rate as Predictors of Outcome after Surgery. Anesthesiology. 118(4). 809–824. 70 indexed citations
10.
Irving, Michelle, Allison Tong, Stephen Jan, et al.. (2011). Factors that influence the decision to be an organ donor: a systematic review of the qualitative literature. Nephrology Dialysis Transplantation. 27(6). 2526–2533. 195 indexed citations
11.
Razavian, Mona, Emma Heeley, Vlado Perkovic, et al.. (2011). Cardiovascular risk management in chronic kidney disease in general practice (the AusHEART study). Nephrology Dialysis Transplantation. 27(4). 1396–1402. 46 indexed citations
12.
Howard, Kirsten, Stephen Jan, John M. Rose, et al.. (2011). Community Preferences for the Allocation & Donation of Organs - The PAraDOx Study. BMC Public Health. 11(1). 386–386. 13 indexed citations
13.
Badve, Sunil V., Matthew A. Roberts, Carmel M. Hawley, et al.. (2011). Effects of Beta-Adrenergic Antagonists in Patients With Chronic Kidney Disease. Journal of the American College of Cardiology. 58(11). 1152–1161. 122 indexed citations
14.
Jardine, Meg, Nicholas A. Gray, Rosemary Masterson, et al.. (2010). Outcomes associated with extended hours haemodialysis (EHHD). Nephrology. 15. 38–38. 2 indexed citations
15.
Perkovic, Vlado, Christine Verdon, Toshiharu Ninomiya, et al.. (2008). The Relationship between Proteinuria and Coronary Risk: A Systematic Review and Meta-Analysis. PLoS Medicine. 5(10). e207–e207. 166 indexed citations
16.
Chalmers, John, Vlado Perkovic, T. Ninomiya, et al.. (2008). Renoprotection with perindopril-indapamide below current recommended blood pressure targets in patients with type 2 diabetes mellitus: Results of the ADVANCE trial. Journal of Hypertension. 26. 1 indexed citations
17.
Cass, Alan, et al.. (2007). Trends in the incidence of treated end‐stage kidney disease among Indigenous Australians and access to treatment. Australian and New Zealand Journal of Public Health. 31(5). 419–421. 37 indexed citations
18.
Cass, Alan, et al.. (2007). Kidney disease in Aboriginal and Torres Strait Islander peoples. Aboriginal health worker. 31(1). 3. 7 indexed citations
19.
Anderson, Kate, Alan Cass, Joan Cunningham, et al.. (2006). Psychosocial criteria in Australian practice guidelines for determining patient suitability for kidney transplantation. CDU eSpace Institutional Repository (Charles Darwin University). 1 indexed citations
20.
Cass, Alan, Joan E. Cunningham, & Wendy E. Hoy. (2002). The relationship between the incidence of end-stage renal disease and markers of socioeconomic disadvantage. New South Wales Public Health Bulletin. 13(7). 147–147. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026